Lasers in Surgery and Medicine
Effects of Myogenic Precursor Cells (C2C12) Transplantation
and Low-Level Laser Therapy on Muscle Repair
Lucas Andreo,
1
Raquel A. Mesquita-Ferrari, PhD,
1,2Ã
Beatriz G. Ribeiro, PhD,
2
Adriana Benitte,
3
Tatiane de F atima Nogueira,
3
Cristiane M. Franc ¸a, PhD,
1
Daniela de F atima Teixeira da Silva, PhD,
1
Sandra K. Bussadori, PhD,
1,2
Kristianne P.S. Fernandes, PhD,
1
Fernanda I. Corr^ ea, PhD,
2
and Jo~ ao C.F. Corr^ ea, PhD
2
1
Postgraduate Program in Biophotonics Applied to Health Sciences, Universidade Nove de Julho (UNINOVE), S ~ ao
Paulo, SP, Brazil
2
Postgraduate Program in Rehabilitation Sciences, UNINOVE, S ~ ao Paulo, SP, Brazil
3
UNINOVE, S ~ ao Paulo, SP, Brazil
Objective: The aim of the present study was to evaluate
the effects of myoblast inoculation in combination with
photobiomodulation therapy (PBMT) on skeletal muscle
tissue following injury.
Materials and Methods: Sixty-five Wistar rats were
divided into five groups: Control—animals not submitted
to any procedure; Injury—cryoinjury of the tibialis
anterior muscle; HBSS—animals submitted to cryoinjury
and intramuscular Hank’s Balanced Salt Solution; Injury
þ Cells—animals submitted to cryoinjury, followed by
myogenic precursor cells (C2C12) transplantation; Injury
þ Cells þ LLLT—animals submitted to cryoinjury, fol-
lowed by myogenic precursor cells (C2C12) transplanta-
tion and PBMT (780 nm, 40 mW, 3.2 J in 8 points). The
periods analyzed were 1, 3, and 7 days. The tibialis anterior
muscle was harvest for histological analysis, collagen
analysis, and immunolabeling of macrophages.
Results: No differences were found between the HBSS group
and injury group. The Injury þ Cells group exhibited an
increase of inflammatory cells and immature fibers as well as
a decrease in the number of macrophages on Day 1. The
Injury þ Cells þ LLLT group exhibited a decrease in myonec-
rosis and inflammatory infiltrate at 7 days, but an increase in
inflammatory infiltrate at 1 and 3 days as well as an increase
in blood vessels at 3 and 7 days, an increase in macrophages at
3 days and better collagen organization at 7 days.
Conclusion: Cell transplantation combined with PBMT
led to an increase in the number of blood vessels, a
reduction in myonecrosis and total inflammatory cells as
well as better organization of collagen fibers during the
skeletal muscle repair process. Lasers Surg. Med. © 2018
Wiley Periodicals, Inc.
Key words: laser therapy; skeletal muscle; cell trans-
plantation; myoblasts
INTRODUCTION
Skeletal muscle is composed of muscle fibers and
satellite cells surrounded by extracellular matrix. Satellite
cells are the stem cells of skeletal muscle and provide the
capacity of adaptation and regeneration. These cells are
undifferentiated and remain in a quiescent state until
activated by different stimuli, such as repair after muscle
transplantation, repair after exercised-induced muscle
injury, the recovery of strength after atrophy due to disuse,
and in cases of muscular dystrophy [1,2]. Following an
injury, skeletal muscle tissue undergoes a repair process
involving degeneration, inflammation, regeneration, fibro-
sis, and remodeling. The activation of satellite cells is
necessary for the genesis of new skeletal muscle fibers [3].
The therapeutic potential of satellite cells has been
explored and described in several studies. The two keys to
the treatment of muscular dystrophy are gene therapy and
cell therapy (or cell transplantation) due to the increase
myogenic capacity. Transplantation cells need to have
myogenic potential and therefore must do at least one of
the following: form new myofibers, generate new satellite
cells, and incorporate their nuclei into the myofibers [2].
The main components of muscle regeneration are satellite
cells and myoblasts. The inoculation of these cells has been
performed in clinical trials. The first study involving
myoblast transplantation in patients with Duchenne
muscular dystrophy (DMD) demonstrated that transplan-
tation can produce gene complementation; MT myofibers
expressed donor-derived dystrophin in one of six patients
after 6 months [4]. In another study, this occurred in eight
of nine patients after 1 month [5]. One specific myoblast
Conflict of Interest Disclosures: All authors have completed
and submitted the ICMJE Form for Disclosure of Potential
Conflicts of Interest and none were reported.
Contract grant sponsor: UNINOVE; Contract grant sponsor:
Conselho Nacional de Desenvolvimento Cient ıfico e Tecnol ogico;
Contract grant number: 305739/2014 RAMF; Contract
grant sponsor: Coordenac ¸ ~ ao de Aperfeic ¸oamento de Pessoal do
N ıvel Superior; Contract grant numbers: 1550120 LADS,
1183510 LADS, 1510536 BGR; Contract grant sponsor: Fundac ¸ ~ ao
de Amparo a Pesquisa do Estado de S~ ao Paulo; Contract
grant number: 2014/12381-1 RAMF.
Ã
Correspondence to: Profa Dra. Raquel Agnelli Mesquita-
Ferrari, Postgraduate Program in Biophotonics Applied to
Health Sciences, Universidade Nove de Julho (UNINOVE), Rua
Vergueiro, 235/249. CEP 01504001, S~ ao Paulo, SP, Brazil. E-
mail: raquel.mesquita@gmail.com
Accepted 13 January 2018
Published online in Wiley Online Library
(wileyonlinelibrary.com).
DOI 10.1002/lsm.22798
ß 2018 Wiley Periodicals, Inc.